US 11534495
Tissue factor-targeted antibody-drug conjugate
granted A61KA61K31/40A61K31/4025
Quick answer
US patent 11534495 (Tissue factor-targeted antibody-drug conjugate) held by SHANGHAI MIRACOGEN INC. expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SHANGHAI MIRACOGEN INC.
- Grant date
- Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/40, A61K31/4025, A61K31/5365, A61K31/537